Mesalazine granules 1.5 g once-daily maintain remission in patients with ulcerative colitis who switch from other 5-ASA formulations: a pooled analysis from two randomised controlled trials
Alimentary Pharmacology and Therapeutics,  Clinical Article

Lichtenstein GR et al. – Mesalazine granules 1.5 g once–daily is effective for maintenance of remission in ulcerative colitis (UC) patients who switch from other 5–aminosalicylic acid (5–ASA) formulations.

Methods
  • Data from two independent multicenter, randomised, double–blind, placebo–controlled, 6–month trials evaluating patients with UC in remission were combined for analysis of a subpopulation of patients who switched from other 5–ASA formulations to MG 1.5 g or placebo upon randomisation.
  • The primary endpoint was the percentage of patients who remained relapse–free at Month 6 or end of treatment.
  • Relapse was defined as a Sutherland Disease Activity Index (SDAI) rectal bleeding score ≥1 and mucosal appearance score ≥2, a UC flare or medication used to treat a UC flare.

Results
  • Of the 487 patients who received 5–ASA maintenance therapy at enrolment, 322 were in the MG group and 165 were in the placebo group.
  • The percentage of patients who remained relapse–free (based on Sutherland Disease Activity Index scores) after 6 months was significantly higher with MG than placebo (78.3% vs. 58.8%, P < 0.001).
  • Rectal bleeding, stool frequency and the physician's rating of disease activity remained unchanged after 6 months in a higher percentage of patients using MG compared with those on placebo (P < 0.004 for each endpoint).

Please login or register to follow this author.
Are you sure you want to Unfollow this Author?
► Click here to access PubMed, Publisher and related articles...
<< Previous Article | Next Article >>

    Currently, there are no available articles.

Your Unread Messages in Internal Medicine

See All >> Messages include industry-sponsored communications and special communications from MDLinx

Most Popular Internal Medicine Articles

Indexed Journals in Internal Medicine: New England Journal of Medicine, The Lancet, Archives of Internal Medicinemore

Register now to view all the MDLinx contents (FREE)!

  • Stay current on the latest literature, research and clinical news
  • Get special communications and offers from MDLinx and our sponsors
  • Receive invitations to paid market research
View Samples and Register

Connect with us, stay current.

Receive the latest mecial news
updates for free via email

Sign up!

Subscribe to our free RSS feeds:

Get the latest news in your specialty automatically added to your newsreader or your personal My Yahoo!, Google, My MSN or My AOL page. Learn More

Close